Autopsy report · NCT01365910
Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
Cause of deathFutility
“Interim analysis determined the study did not meet criteria to proceed”
Life of this trial
- Ran for about 2 years before it stopped.
- 30 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer
- Interventions
- linifanib
- Participants
- 30
- Sites
- 2
- Countries
- United States
Trials that died the same way
- Study of Pemetrexed for Second-Line Pancreas Cancer
“At interim analysis the study did not meet the response criteria to continue” - Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke
“The interim analysis of another associated study is not very effective” - Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
“Study terminated as a result of interim analysis not meeting predetermined criteria.” - Adherence to Antidepressant Treatment in Subjects With Depression
“The study was terminated early based on the planned interim analysis that did not meet criteria for continuation.” - Moxonidine in Patients Undergoing Vascular Surgery
“Study was stopped after pre-definied interim analysis because of no effects”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.